These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 6938033)

  • 1. Serial bone scanning in the evaluation of stage and clinical course in carcinoma of the prostate.
    Johansson JE; Beckman KW; Lindell D; Lingårdh ; Rydman H; Vikterlöf KJ
    Scand J Urol Nephrol Suppl; 1980; 55():31-6. PubMed ID: 6938033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone scanning and plasma phosphatases in carcinoma of the prostate.
    O'Donoghue EP; Constable AR; Sherwood T; Stevenson JJ; Chisholm GD
    Br J Urol; 1978 May; 50(3):172-7. PubMed ID: 753455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cancer of the prostate: value of bone scintigraphy. Point of view].
    Lumbroso J; Guermazi F; Wibault P; Henry-Amar M; Travagli JP
    Bull Cancer; 1985; 72(5):436-41. PubMed ID: 3907735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The bone scan as a tumour marker in prostatic carcinoma.
    Chisholm GD; Stone AR; Beynon LL; Merrick MV
    Eur Urol; 1982; 8(5):257-60. PubMed ID: 6288389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of bone scanning in the assessment of prostatic carcinoma.
    McGregor B; Tulloch AG; Quinlan MF; Lovegrove F
    Br J Urol; 1978 May; 50(3):178-81. PubMed ID: 753456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of raised prostatic acid phosphatase and negative skeletal scintigraphy in prostatic cancer.
    Goodman CM; Cumming JA; Ritchie AW; Chisholm GD
    Br J Urol; 1991 Jun; 67(6):622-5. PubMed ID: 2070208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparative evaluation of serum acid phosphatases, conventional x-ray diagnosis, bone biopsy and Sr 85-bone scanning in the diagnosis of osseous metastases in cancer of the prostate].
    Graber P; Rutishauser G; Baumann JM
    Urologe; 1971 Mar; 10(2):60-2. PubMed ID: 5577980
    [No Abstract]   [Full Text] [Related]  

  • 8. Bone marrow aspiration biopsy and bone scanning in the staging of prostatic cancer.
    Varenhorst E; Alund G; Lindström E; Månson JC
    Br J Urol; 1983 Oct; 55(5):534-7. PubMed ID: 6626900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Phosphatases and bone scan in prostatic cancer].
    Urrutia M; Montero J; Grade J; Llopis M
    Actas Urol Esp; 1977; 1(4):207-12. PubMed ID: 567001
    [No Abstract]   [Full Text] [Related]  

  • 10. Radioimaging of the prostate and metastases of prostatic carcinoma with 99mTc-labelled prostatic acid phosphatase-specific antibodies and their Fab fragments.
    Vihko P; Heikkilä J; Kontturi M; Wahlberg L; Vihko R
    Ann Clin Res; 1984; 16(1):51-2. PubMed ID: 6742767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The diagnostic value of radiological, nuclear medicine and biochemical methods for detection of bone metastases in carcinoma of the prostate (author's transl)].
    Rost A; Fiedler U; Marshall F; Koppenhagen K
    Radiologe; 1977 Jun; 17(6):249-55. PubMed ID: 887744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of alkaline and acid phosphatase and skeletal scintigraphy in carcinoma of the prostate.
    Merrick MV; Ding CL; Chisholm GD; Elton RA
    Br J Urol; 1985 Dec; 57(6):715-20. PubMed ID: 4084732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The role of bone scintigraphy and its value in the staging and follow up of prostatic carcinoma].
    Adám E; Gervain M; Rajtár M; Oszlánczi J; Csernay L; Scultéty S
    Orv Hetil; 1989 Feb; 130(7):335-40. PubMed ID: 2645558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serial bone scanning: the assessment of treatment response in carcinoma of the prostate.
    Fitzpatrick JM; Constable AR; Sherwood T; Stephenson JJ; Chisholm GD; O'Donoghue EP
    Br J Urol; 1978 Dec; 50(7):555-61. PubMed ID: 753508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of routine followup bone scans after definitive therapy of localized prostatic cancer.
    Huben RP; Schellhammer PF
    J Urol; 1982 Sep; 128(3):510-2. PubMed ID: 6214643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [X-ray survey and radioisotope scanning of the skeleton in the evaluation of bone metastases in prostatic carcinoma].
    Meiraz D; Garti I; Lubin E
    Harefuah; 1978 Nov; 95(10):332-3. PubMed ID: 570535
    [No Abstract]   [Full Text] [Related]  

  • 17. Carcinoma of the prostate: a critical look at staging.
    Bruce AW; O'Cleireachain F; Morales A; Awad SA
    J Urol; 1977 Mar; 117(3):319-22. PubMed ID: 839593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved sensitivity in bone scintigraphy using quantitative spinal profile analysis.
    Parker D; Hart GC
    Nucl Med Commun; 1988 Sep; 9(9):631-7. PubMed ID: 3186084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Correlation between extent of metastatic lesions in whole body bone scintigraphy of patients with prostatic cancer and prostatic acid phosphatase (PAP) in blood by PAP RIA kit "EIKEN" (author's transl)].
    Kida T; Higuchi Y
    Kaku Igaku; 1981 Aug; 18(7):907-15. PubMed ID: 7321322
    [No Abstract]   [Full Text] [Related]  

  • 20. Correlation of neoplasms with incidence and localization of skeletal metastases: An analysis of 1,355 diphosphonate bone scans.
    Tofe AJ; Francis MD; Harvey WJ
    J Nucl Med; 1975 Nov; 16(11):986-9. PubMed ID: 810549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.